Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14370541 | 0.77 | CNR1 (0.97) | CNR1CNR2 | |
| SCHEMBL10606409 | 0.77 | CNR1 (0.42) | CNR1CNR2 | |
| SCHEMBL9116221 | 0.76 | CNR2 (0.43) | CNR1CNR2 | |
| SCHEMBL5346637 | 0.76 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL5356057 | 0.76 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL31591358 | 0.75 | OPRM1 (0.56) | CNR1CNR2 | |
| SCHEMBL6345433 | 0.74 | TYR (0.55) | CNR1CNR2 | |
| SCHEMBL1839805 | 0.72 | CNR2 (0.49) | CNR1CNR2 | |
| SCHEMBL17148818 | 0.72 | CNR2 (0.49) | CNR1CNR2 | |
| SCHEMBL1839224 | 0.72 | CNR2 (0.49) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7285687-B2 | Cannabinoids | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-10-23 | — | — | US | disclosed |
| US-7179800-B2 | Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-02-20 | — | — | US | disclosed |
| US-20050165259-A1 | Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2005-07-28 | — | — | US | disclosed |
| US-20050159449-A1 | Cannabinoids | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2005-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050165259-A1 | Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease | CNR1, CNR2, HRH4 | CNR1 1/4885CNR2 2/4885 |
| US-20050159449-A1 | Cannabinoids | CNR1, CNR2, OPRL1 | CNR1 1/4885CNR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.